Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
33,048,603
-
Shares change
-
+471,245
-
Total reported value, excl. options
-
$881,940,071
-
Value change
-
-$17,562,428
-
Put/Call ratio
-
76%
-
Number of buys
-
98
-
Number of sells
-
-78
-
Price
-
$26.7
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2015
226 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2015.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,048,603 shares
of 80,437,135 outstanding shares and own 41.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,991,960 shares), WELLINGTON MANAGEMENT GROUP LLP (1,968,596 shares), WELLS FARGO & COMPANY/MN (1,910,531 shares), WADDELL & REED FINANCIAL INC (1,793,000 shares), FMR LLC (1,447,813 shares), BlackRock Fund Advisors (1,304,857 shares), BB BIOTECH AG (1,302,912 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,251,141 shares), STATE STREET CORP (1,162,852 shares), and ALLIANCEBERNSTEIN L.P. (1,031,124 shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.